FDAnews Drug Daily Bulletin

NUTRA PHARMA PENETRATES THE CHINA MARKET

Nov. 28, 2005
A A

Nutra Pharma Corp., a biopharmaceutical and diagnostics company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases announced today that it is working with the Business Development Group of Xinhua Finance, China's premier financial services and media company.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-23-2005/0004222094&EDATE=)